| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/03/2003 | EP1339740A2 Methods and cells for detecting modulators of rgs proteins |
| 09/03/2003 | EP1339739A2 Methods and compositions involved in groucho-mediated differentiation |
| 09/03/2003 | EP1339738A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/03/2003 | EP1339737A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/03/2003 | EP1339735A1 Method for preparing tryptophan rich peptides |
| 09/03/2003 | EP1339433A2 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma |
| 09/03/2003 | EP1339427A2 Method of producing biospecific molecules by protein trans-splicing |
| 09/03/2003 | EP1339425A2 Vaccine composition containing transforming growth factor alpha |
| 09/03/2003 | EP1339423A2 Intraflagellar transport |
| 09/03/2003 | EP1095055B1 Method for the production of recombinant peptides with a low amount of trisulfides |
| 09/03/2003 | EP1086246A4 Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer |
| 09/03/2003 | EP1027433B1 Human app or a4ct sequences encoding the mutation i45f |
| 09/03/2003 | EP0973391A4 Endoderm, cardiac and neural inducing factors |
| 09/03/2003 | EP0938678B1 Method and kit for the diagnosis of troponin i |
| 09/03/2003 | EP0927195B1 Process for producing a plasma protein-containing medicament |
| 09/03/2003 | EP0914614B1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrPsc |
| 09/03/2003 | EP0857210B1 Therapeutic antiangiogenic compositions and methods |
| 09/03/2003 | EP0833670B1 Vaccine against rotavirus infection comprising peptides of viral enterotoxin nsp4 |
| 09/03/2003 | EP0828844B1 Promoters for gene expression |
| 09/03/2003 | EP0773030B1 Method of purifying necrotoxin produced by bordetella |
| 09/03/2003 | EP0757994B1 Tcf mutant |
| 09/03/2003 | EP0751780B1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
| 09/03/2003 | EP0737209B1 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies |
| 09/03/2003 | EP0711349B1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 09/03/2003 | EP0684831B1 Allogenic vaccine and method to synthesize same |
| 09/03/2003 | EP0673425B1 Dna encoding chitin deacetylase |
| 09/03/2003 | EP0651646B1 Therapeutic conjugates of toxins and drugs |
| 09/03/2003 | EP0647273B1 Dna sequences encoding oligosaccharide transporter |
| 09/03/2003 | EP0607297B1 Hormone analogs with multiple ctp extensions |
| 09/03/2003 | CN1440459A Expression system |
| 09/03/2003 | CN1440456A Sentinel virus Ôàí" |
| 09/03/2003 | CN1440423A Immunoadhesin for the prevention of rhinovirus infection |
| 09/03/2003 | CN1440421A Structure of G-protein (RGS4) and methods of identifying agonists and antagonists using same |
| 09/03/2003 | CN1440420A Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 09/03/2003 | CN1440419A Compounds and methods for treatment and prevention of bacterial infection |
| 09/03/2003 | CN1440296A Vaccine against foot-and-mouth disease |
| 09/03/2003 | CN1440294A Medical components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
| 09/03/2003 | CN1439663A Method for extracting and purifying cartilage style proteoglycan |
| 09/03/2003 | CN1439649A High efficiency ionic exchange membrane chromatography decontamination vitelloenin technology |
| 09/03/2003 | CN1439424A Anti-SARS virus transfer factor preparation method |
| 09/03/2003 | CN1120174C Process for preparing marine conidae analgesic polypeptide |
| 09/03/2003 | CN1120173C Antitumor substance extracted from Grifola |
| 09/02/2003 | US6613962 Given DNA sequence; insect resistance |
| 09/02/2003 | US6613957 Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic non-human mammals |
| 09/02/2003 | US6613891 Polynucleotides that encode bovine inhibin |
| 09/02/2003 | US6613890 Analogues of Kunitz protease inhibitor domain of amyloid precursor protein bind to and inhibit activity of serine proteases including kallikrein, plasmin, and coagulation factors VIIa, IXa, Xa, XIa, and XIIa; for treating blood loss |
| 09/02/2003 | US6613887 Human ependymin-like protein |
| 09/02/2003 | US6613886 Antibodies that specifically bind a Bacillus thuringiensis toxin receptor |
| 09/02/2003 | US6613884 Method for the removal/purification of serum albumins and means for use in the method |
| 09/02/2003 | US6613883 Screening assays for compounds that cause apoptosis and related compounds |
| 09/02/2003 | US6613882 Use for intracellular transport and membrane presentation of certain epitopes |
| 09/02/2003 | US6613881 Isolated polypeptide of given amino acid sequence; can use in vaccines |
| 09/02/2003 | US6613878 PCNA binding substance |
| 09/02/2003 | US6613877 Polypeptide for use in the diagnosis and treatment of osteoporosis, paget's disease, electrolyte, kidney and heart defects |
| 09/02/2003 | US6613874 Melanocortin receptor ligands |
| 09/02/2003 | US6613873 Covalently bound to a polyamide backbone; given formula; exhibit increased sequence specificity and binding affinity; resistant to enzyme degradation |
| 09/02/2003 | US6613872 Compounds for immunotherapy of prostate cancer and methods for their use |
| 09/02/2003 | US6613750 Inhibiting growth of a tumor cell by introducing to the cell an effective amount of p19ARF protein or mimetic thereof, and p53 |
| 09/02/2003 | US6613746 Cell adhesion proteins having cells with glycoprotein antibodies and carbohydrate determinants used to interfere with binding FC receptor and as complement inhibitors; antiinflammatory agents |
| 09/02/2003 | US6613745 Therapeutic molecules derived from snake venom |
| 09/02/2003 | US6613744 BMP-6 proteins |
| 09/02/2003 | US6613742 Chemokine-derived synthetic peptides |
| 09/02/2003 | US6613740 Activity dependent neurotrophic factor III (ADNF III) |
| 09/02/2003 | US6613737 Fractionating serum/blood plasma by chromatography and electrophoresis; sperm-motility promoting glycoprotein |
| 09/02/2003 | US6613734 Peptides-containing liposomal surfactants |
| 09/02/2003 | US6613569 Inducible packaging cell lines for lentivirus vectors |
| 09/02/2003 | US6613565 Use of delta-like protein to inhibit the differentiation of stem cells |
| 09/02/2003 | US6613563 Viral vectors with modified tropism |
| 09/02/2003 | US6613557 Recombinant DNA molecules which encode viral protein; transfecting a host cell with the DNA molecules; used for diagnostic purposes or for incorporation in a vaccine |
| 09/02/2003 | US6613556 Infecting cells from a continuous epithelial or fibroblast cell line, free of contaminants, with a high titer growth strain of dengue virus; use in vaccine production |
| 09/02/2003 | US6613548 Fusion products containing insoluble proteinaceous tag |
| 09/02/2003 | US6613547 Nucleotides; signal sequences; DNA sequences; Saccharomyces; vectors/genetic/; yeasts; proteins; use of recombinant DNA containing transcription sequences in the production of proteins of interest |
| 09/02/2003 | US6613546 DNA; genomes; axons; exons; introns; splicing/genetic/; use to produce "useful protein" by animal cells transformed with expression vector comprised of nucleic acid encoding the "useful protein" and linked to DNA having promoter activity |
| 09/02/2003 | US6613545 Corynebacterium glutamicum; transport proteins; isoleucine; leucine; valine; nucleotide sequences; replication/genetic/; use to improve production of title amino acids for use in human medicine, pharmaceutical industry and animal nutrition |
| 09/02/2003 | US6613544 Osteoprotegerin |
| 09/02/2003 | US6613543 Fermentative carotenoid production |
| 09/02/2003 | US6613533 Histamine receptor |
| 09/02/2003 | US6613532 Anti-lamin antibodies, endogeneous inhibitors of thrombosis |
| 09/02/2003 | US6613530 Determination of a specific immunoglobulin using multiple antigens |
| 09/02/2003 | US6613521 Nucleic acids; CARD (Caspase Recruitment Domain) proteins; primers; hybridization probes; use in diagnosis, therapy for disorders from with abnormal levels of apoptotic cell death or abnormal activity of FAS/APO-1 or TNF receptor complexes |
| 09/02/2003 | US6613515 Nucleotide sequences; polynucleotides; carcinoma proteins; polypeptides; antibodies; T-cells; vaccines; drugs; use of polypeptides, antibodies, polynucleotides and T-cells in vaccines and antitumor agents for treatment of ovarian cancer |
| 09/02/2003 | US6613514 Evolving preferential protein; digest nuclelotide sequences substrate, join terminals, screen for preferential proteins, recover nucleotide sequences |
| 09/02/2003 | US6613506 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 09/02/2003 | US6613337 Preventing, treating and detecting leishmaniasis and stimulating immune responses in patients. The compounds provided include polypeptides that contain at least an immunogenic portion of one or more Leishmania antigens. |
| 09/02/2003 | US6613336 H.influenzae type b polysaccharide-substantially pure, refolded meningococcal outer membrane protein conjugate; vaccines |
| 09/02/2003 | US6613335 Provided are BASB011 polypeptides and polynucleotides encoding BASB011 polypeptide from Moraxella catarrhalis. Also provided are immunogenic uses. |
| 09/02/2003 | US6613333 Immunodominant human T-cell epitopes of hepatitis C virus |
| 09/02/2003 | US6613331 Vaccine against Lyme disease |
| 09/02/2003 | US6613329 Vaccine and antitoxin for treatment and prevention of C. difficile disease |
| 09/02/2003 | US6613327 Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signal |
| 09/02/2003 | US6613321 Strain is unable to express homologous O-polysaccharide due to a 1.2 kb deletion that spans the junction of the rfbA and rfbB genes, and expresses a heterologous O-polysaccharide that is covalently linked to a lipopolysaccharide |
| 09/02/2003 | US6613320 Recombinant CD4+ T cells from an individual afflicted with hyper IgM syndrome transformed with vectors carrying either the wild type or the mutagenized CD40Ls, metabolically radiolabeled, and examined for expression |
| 09/02/2003 | US6613319 Long-term expression of erythropoietin and growth hormone by transforming muscle cells |
| 09/02/2003 | US6613318 Methods for identifying inhibitors of GADD45 polypeptide activity, and inhibitors of such activity |
| 08/28/2003 | WO2003071273A1 Method of detecting bond between vitamin d3 derivative and vitamin d3 receptor |
| 08/28/2003 | WO2003071272A1 Method of determining ligand |
| 08/28/2003 | WO2003071268A2 Method for discovering pharmacologically active substances |
| 08/28/2003 | WO2003071267A1 Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors |
| 08/28/2003 | WO2003070987A1 Nucleotide sequence coding for a tolc containing a heterologous amino acid sequence |
| 08/28/2003 | WO2003070981A2 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines |